OCULAR CHANGES IN METASTATIC MELANOMA PATIENTS TREATED WITH MEK INHIBITOR COBIMETINIB AND BRAF INHIBITOR VEMURAFENIB. (2018). Radiology and Oncology, 52(2). https://www.ojstest.computing.si/index.php/ro/article/view/2930